Development Program For Aficamten News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development Program For Aficamten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Program For Aficamten Today - Breaking & Trending Today

Cytokinetics Provides Update on Cardiac Myosin Inhibitor Programs and Plans to Build a Specialty Cardiology Franchise at Virtual Investor & Analyst Day

Published: October 19, 2023

New Long-Term Data from FOREST-HCM, the Open-Label Extension Study of Aficamten,Show Sustained Improvements in Clinical Efficacy Endpointsand No Treatment Interruptions for Low Ejection Fraction ...

Source: marketscreener.com

Related Topics:

San FranciscoUnited StatesTheodore AbrahamRoberti BlumDiane WeiserCytokinetics Incorporated NasdaqSymphony HealthSchool Of Cardiovascular Metabolic HealthDivision Of CardiologyAdult Cardiac Echocardiography LaboratoryDevelopment Program For AficamtenGlobenewswire IncCardiovascular Genetics CenterUs Food Drug AdministrationClinical Trials ProgramMarket ResearchCorporate CommunicationsJournal Of The American College CardiologyCytokinetics IncorporatedExchange CommissionClinical ResearchResearch Evaluation Of Sustained TreatmentHarvard Medical SchoolNational Medical Products AdministrationNew Long Term Data